Ofloxacin(OFX) antibody/antigen (BSA/OVA/KLH conjugated hapten)

 Download 

anti-Ofloxacin(OFX) antibody and Carrier-coupled antigen/immunogen (hapten-carrier conjugates)

Go to Antibiotics diagnostics products collection >>

Product information

Size： 1mg | 10mg | 100mg

Product Description

BSA-Ofloxacin(OFX)

OVA-Ofloxacin(OFX)

Anti-Ofloxacin(OFX) mouse monoclonal antibody

Anti-Ofloxacin(OFX) human monoclonal antibody

Reference

Validation Data

Click to get more Data / Case study about the product.

Biomarker Information

Ofloxacin (OFX): A Cornerstone in Veterinary Pharmacology

Ofloxacin, identified as Serial Number 1, stands as a cornerstone in the realm of veterinary pharmacology. It belongs to the fluoroquinolone class of antibiotics, renowned for their potent antimicrobial properties. Specifically engineered to target bacterial infections in animals, OFX is instrumental in combating a broad spectrum of pathogenic bacteria. Its mechanism of action involves inhibiting bacterial DNA gyrase, a crucial enzyme involved in DNA replication and repair. By disrupting this process, OFX effectively halts bacterial growth and proliferation, making it invaluable in the treatment of diverse bacterial ailments in veterinary practice.

In the context of veterinary drug residues and additives, OFX assumes paramount importance. Veterinary medicine relies heavily on antibiotics like OFX to ensure the health and well-being of animals. However, the challenge lies in maintaining a delicate balance. While these antibiotics are indispensable for treating infections, their residues in animal-derived products must be meticulously regulated. Residues exceeding permissible limits can compromise public health by fostering antibiotic resistance and triggering adverse reactions in consumers. Additionally, regulatory bodies impose stringent guidelines to safeguard both animal and human health, necessitating rigorous monitoring of OFX levels in veterinary products.

The Significance of Accurate OFX Measurement (Serial Number 2)

The meticulous measurement of OFX, indicated as Serial Number 2, holds multifaceted significance within the veterinary industry. One of its primary roles lies in ensuring compliance with regulatory standards and guidelines. Regulatory agencies worldwide stipulate maximum residue limits (MRLs) for OFX in animal-derived products. Adherence to these limits is not only a legal requirement but also a crucial step in mitigating the emergence of antibiotic-resistant strains. By precisely measuring OFX levels, veterinarians and livestock producers can guarantee that their products meet these stringent regulatory criteria, thereby upholding the safety of the food supply chain.

Furthermore, accurate quantification of OFX is vital for quality control in the production of animal feed and pharmaceutical formulations. Animal feed manufacturers must adhere to strict quality standards to provide balanced and safe nutrition to livestock. Ensuring the absence of excess OFX residues in animal feed is imperative to prevent unintended antibiotic exposure among animals. Likewise, pharmaceutical formulations containing OFX must be consistently dosed to guarantee their therapeutic efficacy. Precise measurement techniques not only validate the effectiveness of these formulations but also contribute to the overall health and productivity of livestock.

Our biopharmaceutical company recognizes the critical importance of OFX measurement in the veterinary sector. To address this need, we offer a comprehensive range of innovative solutions, including highly specific anti-Ofloxacin antibodies and small molecule competitive antigens. These advanced tools are meticulously developed to facilitate accurate and sensitive quantification of OFX levels in various veterinary matrices. Leveraging state-of-the-art technologies, our products empower veterinarians, researchers, and regulatory authorities to monitor OFX residues effectively, thereby ensuring the safety, quality, and compliance of veterinary products. By choosing our cutting-edge solutions, stakeholders in the veterinary industry can confidently navigate the complexities of OFX measurement, safeguarding both animal and human welfare in the process.

About GDU